Melodiol Global Health (AU:ME1) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Melodiol Global Health Limited has announced the issue of new fully paid ordinary shares without public disclosure as permitted under specific provisions of the Corporations Act. The company confirms compliance with all necessary regulatory requirements and asserts that no material information has been withheld from investors. Melodiol, focusing on cannabis and plant-based health products, aims to improve the lives of people and animals through high-quality offerings.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.